| 000 | 01607 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516024754.0 | ||
| 264 | 0 | _c20110930 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1539-6304 | ||
| 024 | 7 |
_a10.2500/aap.2011.32.3439 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLieberman, Phil | |
| 245 | 0 | 0 |
_aTwo-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis. _h[electronic resource] |
| 260 |
_bAllergy and asthma proceedings _c |
||
| 300 |
_a151-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Allergic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDibenzoxepins _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNasal Mucosa _xdrug effects |
| 650 | 0 | 4 | _aNasal Sprays |
| 650 | 0 | 4 | _aOlopatadine Hydrochloride |
| 650 | 0 | 4 |
_aPhthalazines _xtherapeutic use |
| 650 | 0 | 4 |
_aRhinitis, Vasomotor _xdrug therapy |
| 650 | 0 | 4 | _aTaste |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMeltzer, Eli O | |
| 700 | 1 | _aLaForce, Craig F | |
| 700 | 1 | _aDarter, Amy L | |
| 700 | 1 | _aTort, Maria J | |
| 773 | 0 |
_tAllergy and asthma proceedings _gvol. 32 _gno. 2 _gp. 151-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2500/aap.2011.32.3439 _zAvailable from publisher's website |
| 999 |
_c20627704 _d20627704 |
||